AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

Uses Humira may be prescribed for Crohn's disease or ulcerative colitis, the two main forms of IBD.Humira is approved for use in adults and in children over the age of six. Humira may reduce ...

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

Weight loss may also be related to the condition that you are receiving Humira to treat, such as ulcerative colitis or Crohn’s disease. If you’re concerned about your weight while using Humira ...

The company has a long presence in therapeutics for the disease, with drugs like TNF inhibitor Humira (adalimumab ... “The prevalence of IBD continues to increase, and many people living ...

Humira's sales are declining due to the loss ... especially in the popular inflammatory bowel disease (IBD) space, which includes two conditions — ulcerative colitis (UC) and Crohn’s disease ...

While Humira’s 2023 loss of exclusivity hung over AbbVie’s head for years, the ascent of the Chicago drugmaker’s immunology successors Skyrizi and Rinvoq under prior CEO Richard Gonzalez has swiftl | ...